Singapore markets closed

Teladoc Health, Inc. (TDOC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
14.24-0.36 (-2.47%)
As of 03:05PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.47B
Enterprise value 2.94B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.92
Price/book (mrq)1.06
Enterprise value/revenue 1.13
Enterprise value/EBITDA 19.10

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-42.95%
S&P500 52-week change 325.65%
52-week high 330.41
52-week low 313.59
50-day moving average 316.45
200-day moving average 319.86

Share statistics

Avg vol (3-month) 34.78M
Avg vol (10-day) 34.58M
Shares outstanding 5169.31M
Implied shares outstanding 6167.04M
Float 8165.53M
% held by insiders 10.77%
% held by institutions 174.91%
Shares short (28 Mar 2024) 420.88M
Short ratio (28 Mar 2024) 45.01
Short % of float (28 Mar 2024) 414.20%
Short % of shares outstanding (28 Mar 2024) 412.50%
Shares short (prior month 29 Feb 2024) 421.6M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -8.47%
Operating margin (ttm)-4.53%

Management effectiveness

Return on assets (ttm)-3.01%
Return on equity (ttm)-9.51%

Income statement

Revenue (ttm)2.6B
Revenue per share (ttm)15.81
Quarterly revenue growth (yoy)3.60%
Gross profit (ttm)N/A
Net income avi to common (ttm)-220.37M
Diluted EPS (ttm)-1.34
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.12B
Total cash per share (mrq)6.73
Total debt (mrq)1.6B
Total debt/equity (mrq)68.62%
Current ratio (mrq)3.54
Book value per share (mrq)13.96

Cash flow statement

Operating cash flow (ttm)350.02M
Levered free cash flow (ttm)306M